[Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
The authors provide evidence for the efficacy of the buflomedil-pentoxifylline-defibrotide combination for treatment of lower limb chronic obstructive arterial disease, Fontain stage II. Improvement of walking autonomy obtained with these agents ranged from 50 to 100% in 29 of 36 patients (relative frequency = 0.80).
Marci
M
M
Divisione di Medicina Generale, USL RM/G, Ospedale A. Angelucci di Subiaco.
Albiani
B
B
Ricci
M
M
Russo
F
F
D000368:Aged; D000369:Aged, 80 and over; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010431:Pentoxifylline / Q000627:therapeutic use*; D011089:Polydeoxyribonucleotides / Q000627:therapeutic use*; D011759:Pyrrolidines / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D011089:Polydeoxyribonucleotides; D011759:Pyrrolidines; D014665:Vasodilator Agents; C036901:defibrotide; D010431:Pentoxifylline; C010651:buflomedil
Trattamento delle arteriopatie obliteranti croniche degli arti inferiori al secondo stadio di Fontaine. Osservazioni personali con l'impiego dell'associazione buflomedil-pentossifillina-defibrotide.